Viridian Therapeutics, Inc. (VRDN): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2014-12-31, 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Gross Profit is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$929.0K
Year ended 2016-12-31
$1.54M2013-12-31: $1.54M2014-12-31: $954.0K2015-12-31: $66.0K2016-12-31: $929.0K$929.0K
2013-12-31 Gross Profit (USD) 2016-12-31
Period endedGross ProfitChange YoYSource filing
2016-12-31$929.0Kn/c2018-03-15, From 2016-01-01
2015-12-31$66.0K-93.1%2017-03-24, From 2015-01-01
2014-12-31$954.0Kn/c2016-03-21, From 2014-01-01
2013-12-31$1.54Mn/a2015-03-27, From 2013-01-01